Clinical Trial Detail

NCT ID NCT02848001
Title A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

CC-90009

Age Groups: senior adult

No variant requirements are available.